With body fat distribution representing a major determinant of metabolic disease risk [13], it is notable that BMP2 exerts depot-specific pro-adipogenic effects in murine cells; visceral preadipocytes are reportedly more sensitive to the pro-adipogenic effects of BMP2 compared to their subcutaneous counterparts [14]. Here, BMP2 is linked to Other metabolic disease.